Cancer Immunotherapy Novel Targets and Immunotherapy are being finely tuned to optimise efficacy and minimise side effects, gradually becoming a standard, perhaps even predominant, method in cancer management.

Looking at new pathways for ICIs and Compugen's triple pathway hypothesis may be paving the way for next-generation cancer immunotherapy.

Discover the transformative role of AI in the world of biotechnology. Dive deep into its synergy with 3D modeling, revealing groundbreaking advancements in cell & gene therapy and faster, more efficient drug development cycles.

Professors Katalin Karikó and Drew Weissman have been awarded the 2023 Nobel Prize in Medicine for their contributions to the development of the COVID-19 mRNA vaccine.

The company can now sell their biologic for ulcerative colitis in a subcutaneous form on the US market.

Our ‘Navigating the Regulatory Landscape' eBook has been designed to provide you with invaluable insights into the intricacies of regulations & policies surrounding the challenges and opportunities of Real-World Data, genome editing, biomedical informatics, manufacturing and many more.

Adaptimmune has developed from a strategic collaboration with GSK and embarked on a highly successful journey towards developing cancer immunotherapy treatments.

Our ‘Navigating the Regulatory Landscape’ eBook has been designed to provide you with invaluable insights into the intricacies of regulations & policies surrounding the challenges and opportunities of Real-World Data, genome editing, biomedical informatics, manufacturing and many more.

The approval follows positive results from Genmab's 'Epcore' phase I/II clinical trial.

What are the regulatory considerations that need to be made in the clinic for oligonucleotide therapies? What's the existing guidance for this emerging modality?

Here, we investigate some of the main trends and challenges in peptide bioanalysis such as non-specific binding, and look at how they can be circumvented.